Financing, Equity Capital Markets

Aptose Biosciences Inc.

12/19
|
$74.2 Million
Piper Sandler served as sole bookrunner for Aptose Biosciences Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma